IRCT20210714051887N1CompletedPhase 3
The effect of plasma therapy in the treatment of patients with COVID-19 infection. Randomized, open-label
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 29
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Willingness to participate in the studyPeople over the age of 18People with severe form of COVID-19 disease (shortness of breath, respiratory frequency = 30 / min,, blood oxygen saturation = 93%,, partial pressure of arterial oxygen to fraction of inspired oxygen ratio <300,, percentage of pulmonary involvement more than 50 in 24-48 hours,)
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
The effect of Plasmapheresis in the treatment of patients with COVID-19IRCT20200611047735N2Bandare-abbas University of Medical Sciences45
Completed
Not Applicable
Effects of Platelet Rich Plasma in Treatment of patients with Long Bones Non-unionsonunion of fracture.Nonunion of fracture [pseudarthrosis]IRCT201208262445N1Trauma Research Center70
Completed
Not Applicable
Study of the effects of therapeutic plasmapheresis in comparison with corticosteroid therapy on the immune system of MS patientsMultiple sclerosisMultiple sclerosis.IRCT2012072110349N1Isfahan University of Medical Sciences10
Recruiting
Phase 2
Evaluation of the effect of plasmapheresis in the treatment of Covid 19IRCT20200405046958N2Mashhad University of Medical Sciences42
Recruiting
Not Applicable
Effects of Platelet in the treatment of wounds in patients with Diabetesower limb ulcer, not elsewhere classifiedC18.452.394.750Diabetes MellitusRBR-6yt2hpniversidade Brasil